IP Library Granted Patent US 8,101,752
Granted Patent B2
US 8,101,752 · App. 11/913,200 · Granted Jan 24, 2012

Process for preparing 4-[(1,6-dihydro-6-oxo-2-pyrimidinyl)amino]benzonitrile

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,101,752
App. No.
11/913,200
Granted
Jan 24, 2012
Kind
B2
Abstract

This invention relates to a process for preparing 4-[(1,6-dihydro-6-oxo-2-pyrimidinyl)-amino]benzonitrile (I) starting from a 4-oxo-1,6-dihydro-pyrimidinylcarboxylic acid ester (II) or starting from a guanidine derivative which is reacted with an alkoxy-methylene malonic acid ester to an ester (II) which is converted to (I), which reaction sequence may be a one-pot procedure.

Claims (16)

1. A process for preparing a compound of formula (I)

wherein the compound of formula (I) is prepared by condensing the guanidine of formula (III) with an alkoxymethylene malonic acid ester of formula (IV), followed by a dealkoxycarbonylation to obtain the desired end product of formula (I), as outlined in the following reaction scheme, wherein each R, independently from the other radicals R, is C 1-4 alkyl:

2. A process according to claim 1 wherein the conversion from (III) to obtain (I) is conducted in a one-pot reaction.

3. A process according to claim 1 wherein R is methyl or ethyl.

4. A process according to claim 1 wherein the process is conducted in the presence of a salt.

5. A process according to claim 4 wherein the salt is represented by formula MX wherein M is a metal or ammonium or substituted ammonium, and X is an anion having nucleophilic properties.

6. A process according to claim 5 wherein M is an alkali metal, ammonium or substituted ammonium and X is a halide, cyanide or C 1-4 alkylcarboxylate.

7. A process according to claim 1 wherein the process is conducted in a dipolar aprotic solvent.

8. A process according to claim 7 wherein the solvent is selected from dimethylformamide (DMF), dimethylacetamide (DMA), hexamethylphosphoric acid triamide (HMPT), N-methylpyrrolidone (NMP), dimethylsulfoxide (DMSO) and acetonitrile.

9. A process according to claim 1 wherein at the end of the dealkoxycarbonylation step an acid is added to the reaction mixture.

10. The process according to claim 6 , wherein M is an alkali metal and X is C 1-4 alkylcarboxylate.

11. The process according to claim 9 , wherein the acid is an alkylcarbonic acid.

12. A process according to claim 10 , wherein the solvent in N-methylpyrrolidone.

13. A process according to claim 11 , wherein the acid is a C 1-4 alkylcarbonic acid.

14. A process according to claim 13 , wherein the acid is acetic acid.

15. A process according to claim 4 , wherein the salt is sodium acetate.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 24, 2015
From: JANSSEN R & D IRELAND
To: JANSSEN SCIENCES IRELAND UC
Reel/Frame 035496/0382 →
CHANGE OF NAME Recorded Apr 15, 2015
From: TIBOTEC PHARMACEUTICALS
To: JANSSEN R&D IRELAND
Reel/Frame 035439/0981 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 20, 2007
From: SHILS, DIDIER PHILIPPE ROBERT; STAPPERS, ALFRED ELISABETH
To: JANSSEN PHARMACEUTICA N.V.
Reel/Frame 020276/0148 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 20, 2007
From: JANSSEN PHARMACEUTICA N.V.
To: TIBOTEC PHARMACEUTICALS LTD.
Reel/Frame 020276/0192 →